C4.4A is associated with tumor budding and epithelial–mesenchymal transition of colorectal cancer
Open Access
- 8 March 2012
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 103 (6) , 1155-1164
Abstract
C4.4A is a glycolipid‐anchored membrane protein expressed in several human malignancies. The aim of this study was to explore the association between C4.4A expression at the invasion front of colorectal cancer (CRC) and tumor budding, a putative hallmark of cell invasion of CRC. Advanced CRCs (T2–4, n = 126) had a budding count of 3.66 ± 5.66, which was significantly higher than that of T1 early CRCs (1.75 ± 2.78, n = 87). C4.4A‐positive CRC specimens showed a larger budding cell number than C4.4A‐negative CRC specimens in T1 CRCs, and especially advanced CRCs (9.45 ± 5.83 vs 1.60 ± 3.93). Furthermore, we found a correlation between the percentage of C4.4A‐positive cases and budding count in advanced CRC. Multivariate analysis for patients' survival showed that C4.4A was superior to tumor budding as a prognostic factor. With siRNA treatment, C4.4A levels were associated with cell invasion, but not with proliferation, in HCT116 and DLD1 cell lines. An immunohistochemical study in a subset of CRCs showed no relationship between C4.4A and Ki‐67 proliferation marker. In vitro assays using HCT116 indicated that C4.4A levels correlated well with epithelial–mesenchymal transition (EMT) with regard to cell morphology and alterations of EMT markers including E‐cadherin, vimentin, and partially N‐cadherin. We also found that C4.4A expression was significantly associated with loss of E‐cadherin and gain of β‐catenin in clinical CRC tissue samples. These findings suggest that a tight association between C4.4A and tumor budding may, in part, be due to C4.4A promoting EMT at the invasive front of CRC. (Cancer Sci 2012; 103: 1155–1164)Keywords
This publication has 33 references indexed in Scilit:
- Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinomaJournal of Oral Pathology & Medicine, 2011
- Epithelial–mesenchymal transition with expression of SNAI1-induced chemoresistance in colorectal cancerBiochemical and Biophysical Research Communications, 2009
- Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagusBritish Journal of Cancer, 2009
- Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growthsScandinavian Journal of Gastroenterology, 2009
- Expression of E-cadherin and β-catenin is Altered at Tumor Budding Sites, Whose Number is Associated with the Progression of Colorectal CarcinomaThe Korean Journal of Pathology, 2009
- Multivariate Analysis of the Pathologic Features of Esophageal Squamous Cell Cancer: Tumor Budding Is a Significant Independent Prognostic FactorAnnals of Surgical Oncology, 2008
- C4.4A as a candidate marker in the diagnosis of colorectal cancerBritish Journal of Cancer, 2007
- Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancerBritish Journal of Cancer, 2007
- Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptorBiochemical Journal, 2004
- Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumorOncogene, 1998